Serine protease inhibitor, SerpinA3n, regulates cardiac remodelling after myocardial infarction
Cardiovascular Research · 2024
DOI: 10.1093/cvr/cvae075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2024. Verfasst von Qihao Sun und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, University of California, 675 Charles E Young Drive South, Los Angeles, California, 90095 CA, USA. Hauptthemen laut MEDLINE: Myocardial Infarction, Ventricular Remodeling, Mice, Knockout, Disease Models, Animal. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Department of Defense, USA, National Institutes of Health, USA.
Abstract (Originalsprache)
Aims
Following myocardial infarction (MI), the heart repairs itself via a fibrotic repair response. The degree of fibrosis is determined by the balance between deposition of extracellular matrix (ECM) by activated fibroblasts and breakdown of nascent scar tissue by proteases that are secreted predominantly by inflammatory cells. Excessive proteolytic activity and matrix turnover has been observed in human heart failure, and protease inhibitors in the injured heart regulate matrix breakdown. Serine protease inhibitors (Serpins) represent the largest and the most functionally diverse family of evolutionary conserved protease inhibitors, and levels of the specific Serpin, SerpinA3, have been strongly associated with clinical outcomes in human MI as well as non-ischaemic cardiomyopathies. Yet, the role of Serpins in regulating cardiac remodelling is poorly understood. The aim of this study was to understand the role of Serpins in regulating scar formation after MI. Methods and results Using a SerpinA3n conditional knockout mice model, we observed the robust expression of Serpins in the infarcted murine heart and demonstrate that genetic deletion of SerpinA3n (mouse homologue of SerpinA3) leads to increased activity of substrate proteases, poorly compacted matrix, and significantly worse post-infarct cardiac function. Single-cell transcriptomics complemented with histology in SerpinA3n-deficient animals demonstrated increased inflammation, adverse myocyte hypertrophy, and expression of pro-hypertrophic genes. Proteomic analysis of scar tissue demonstrated decreased cross-linking of ECM peptides consistent with increased proteolysis in SerpinA3n-deficient animals.
Conclusion
Our study demonstrates a hitherto unappreciated causal role of Serpins in regulating matrix function and post-infarct cardiac remodelling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, University of California, 675 Charles E Young Drive South, Los Angeles, California, 90095 CA, USA.
- Cardiovascular Theme, David Geffen School of Medicine, University of California, 675 Charles E Young Drive South, Los Angeles, California, 90095 CA, USA.
- Department of Molecular, Cell & Developmental Biology, University of California, 610 Charles E Young Dr S, Los Angeles, California, 90095 CA, USA.
- Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research, University of California, 615 Charles E Young Drive S, Los Angeles, California, 90095 CA, USA.
- Molecular Biology Institute, University of California, 610 Charles E Young Dr S, Los Angeles, California, 90095 CA, USA.
- California NanoSystems Institute, University of California, 570 Westwood Plaza, Los Angeles, California, 90095 CA, USA.
ORCID-Profile: Feiyang Ma
Förderung
- NHLBI NIH HHS
- Department of Defense, USA
- National Institutes of Health, USA
- NIAMS NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Sun, Q., Chen, W., Wu, R., Tao, B., Wang, P., Sun, B., Alvarez, J. F., Ma, F., Galindo, D. C., Maroney, S. P., Saviola, A. J., Hansen, K. C., Li, S., & Deb, A. (2024). Serine protease inhibitor, SerpinA3n, regulates cardiac remodelling after myocardial infarction. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae075
Vancouver
Sun Q, Chen W, Wu R, Tao B, Wang P, Sun B, et al. Serine protease inhibitor, SerpinA3n, regulates cardiac remodelling after myocardial infarction. Cardiovascular Research. 2024. doi:10.1093/cvr/cvae075
BibTeX
@article{Sun2024,
author = {Sun, Qihao and Chen, Wei and Wu, Rimao and Tao, Bo and Wang, Ping and Sun, Baiming and Alvarez, Juan F and Ma, Feiyang and Galindo, David Ceja and Maroney, Sean P and Saviola, Anthony J and Hansen, Kirk C and Li, Shen and Deb, Arjun},
title = {Serine protease inhibitor, SerpinA3n, regulates cardiac remodelling after myocardial infarction},
journal = {Cardiovascular Research},
year = {2024},
doi = {10.1093/cvr/cvae075}
}
EUVIMED